Cita APA

Tam, C. S., Allan, J. N., Siddiqi, T., Kipps, T. J., Jacobs, R., Opat, S., . . . Ghia, P. (2022). Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL.

Citación estilo Chicago

Tam, Constantine S.|||0000-0002-9759-5017, et al. Fixed-duration Ibrutinib Plus Venetoclax for First-line Treatment of CLL. 2022.

Cita MLA

Tam, Constantine S.|||0000-0002-9759-5017, et al. Fixed-duration Ibrutinib Plus Venetoclax for First-line Treatment of CLL. 2022.